Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY3127804 |
Trade Name | |
Synonyms | LY-3127804|LY 3127804|Zansecimab |
Drug Descriptions |
LY3127804 is an antibody that targets Angiopoietin-2 (Ang2), resulting in reduced angiogenesis, and potentially resulting in decreased tumor growth in combination with other agents (AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 3259, PMID: 32741971). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C177075 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY3127804 | LY3127804 | 0 | 1 |
LY3127804 + Ramucirumab | LY3127804 Ramucirumab | 0 | 0 |